This is the start of a very long road (at a minimum a year, but probably more like two) if the vaccine is even effective, but it is good to see the first patient in (FPI) for the phase 1 safety study in healthy volunteers.
BC
COI statement: I work for Genentech, a member of the Roche group. The company is not involved in these vaccine efforts.